Inici
Publicacions
Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg)

Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg)

Data de publicació: 01/10/2021 Data Ahead of Print: 01/06/2021

Autors de IIS La Fe

Jorge Sancho Muriel

Autor
Matteo Frasson

Autor

Autors aliens a IIS La Fe

Rottoli, M
Pellino, G
Tanzanu, M
Baldi, C
Frontali, A
Carvello, M
Foppa, C
Kontovounisios, C
Tekkis, P
Colombo, F
Danelli, P
Celentano, V
Spinelli, A
Panis, Y
Sampietro, GM
Poggioli, G

Grups d'Investigació

Cirugía digestiva y Cuidados perioperatorios

Leader

Matteo Frasson

Abstract

Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis. A total of 91 patients with Crohn's disease (54, 59.3%) or ulcerative colitis (37, 40.7%), 66 (72.5%) had surgery in one of the COVID-19-treatment hospitals, while 25 (27.5%) in the COVID-19-free centre. More COVID-19-treatment patients required urgent surgery (48.4% vs. 24%, p = 0.035), did not discontinue biologic therapy (15.1% vs. 0%, p = 0.039), underwent surgery without a SARS-CoV-2 test (19.7% vs. 0%, p = 0.0033), and required intensive care admission (10.6% vs. 0%, p = 0.032). Three patients (4.6%) had a SARS-CoV-2 infection postoperatively. Postoperative complications were associated with the use of steroids at surgery (Odds ratio [OR] = 4.10, 95% CI 1.14-15.3, p = 0.03), presence of comorbidities (OR = 3.33, 95% CI 1.08-11, p = 0.035), and Crohn's disease (vs. ulcerative colitis, OR = 3.82, 95% CI 1.14-15.4, p = 0.028). IBD patients can undergo surgery regardless of the COVID-19 status of the referral centre. The risk of SARS-CoV-2 infection should be taken into account.

Dades de la publicació

ISSN/ISSNe:: 2038-131X, 2038-3312
Tipus:: Article
Pàgines:: 1811-1818
DOI:: 10.1007/s13304-021-01119-y
PubMed:: 34176073
Factor d'Impacte:: 0,577 SCImago ℠
Quartil:: Q2 SCImago ℠

Documents

No hi ha documents

Mètriques

Filiacions

Rottoli, M:: IRCCS Azienda Osped Univ Bologna, Surg Alimentary Tract, Bologna, Italy

Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Via Massarenti 9, I-40138 Bologna, Italy
Pellino, G:: Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Naples, Italy

Vall dHebron Univ Hosp, Colorectal Surg, Barcelona, Spain
Tanzanu, M:: IRCCS Azienda Osped Univ Bologna, Surg Alimentary Tract, Bologna, Italy

Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Via Massarenti 9, I-40138 Bologna, Italy
Baldi, C:: Osped Rho ASST Rhodense, Div Chirurg Gen & Epatobiliopancreat, Milan, Italy
Frontali, A:: Univ Denis Diderot Paris VII, Beaujon Hosp, AP HP, Dept Colorectal Surg,Pole Malad Appareil Digestif, Clichy, France
Carvello, M:: Humanitas Univ, Humanitas Clin & Res Ctr, Dept Biomed Sci, Colon & Rectal Surg Div, Rozzano, MI, Italy
Foppa, C:: Humanitas Univ, Humanitas Clin & Res Ctr, Dept Biomed Sci, Colon & Rectal Surg Div, Rozzano, MI, Italy
Kontovounisios, C:: Imperial Coll, Dept Surg & Canc, London, England

Chelsea & Westminster Hosp NHS Fdn Trust, London, England
Tekkis, P:: Imperial Coll, Dept Surg & Canc, London, England

Chelsea & Westminster Hosp NHS Fdn Trust, London, England
Colombo, F:: Univ Milan, ASST Fatebenefratelli Sacco, Dept Gen Surg, Dept Biomed & Clin Sci L Sacco, Milan, Italy
Sancho-Muriel, J:: Univ Valencia, Hosp Univ & Politecn La Fe, Colorectal Unit, Valencia, Spain
Frasson, M:: Univ Valencia, Hosp Univ & Politecn La Fe, Colorectal Unit, Valencia, Spain
Danelli, P:: Univ Milan, ASST Fatebenefratelli Sacco, Dept Gen Surg, Dept Biomed & Clin Sci L Sacco, Milan, Italy
Celentano, V:: Imperial Coll, Dept Surg & Canc, London, England

Chelsea & Westminster Hosp NHS Fdn Trust, London, England
Spinelli, A:: Humanitas Univ, Humanitas Clin & Res Ctr, Dept Biomed Sci, Colon & Rectal Surg Div, Rozzano, MI, Italy
Panis, Y:: Univ Denis Diderot Paris VII, Beaujon Hosp, AP HP, Dept Colorectal Surg,Pole Malad Appareil Digestif, Clichy, France
Sampietro, GM:: Osped Rho ASST Rhodense, Div Chirurg Gen & Epatobiliopancreat, Milan, Italy
Poggioli, G:: IRCCS Azienda Osped Univ Bologna, Surg Alimentary Tract, Bologna, Italy

Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Via Massarenti 9, I-40138 Bologna, Italy